Australia · Delayed Price · Currency is AUD Qoria Earnings Call Transcripts
Fiscal Year 2026
-
Merger terms were updated with a $100M equity placement and new leadership structure, ensuring strong capital and operational alignment. Combined ARR reached AUD 345M, with robust growth in both Qoria and Aura segments, and the group targets 20% ARR growth and positive free cash flow post-merger.
-
Revenue and ARR grew over 25% year-over-year, with EBITDA up 68% and free cash flow up 51%. Qustodio and K-12 segments delivered strong growth, and the Aura merger is set to create a global digital safety leader. Guidance for ARR growth above 20% is reiterated.
-
The merger forms a $3 billion digital safety leader, combining AI-driven innovation and global reach across family, school, and workplace protection. Integration is progressing smoothly, with strong financial backing and a clear path to profitability by 2026.
-
Record December quarter with ARR up 20% year-over-year and strong free cash flow. Qustodio and Australia/NZ segments grew over 30%, while U.K. is set for acceleration post-integration. Confident in exceeding full-year guidance, with robust pipeline and stable cost base.
-
Cash collections rose 23% year-over-year to AUD 46.3 million, with free cash flow up 50% and upgraded revenue guidance to AUD 145 million. Qustodio drove 33% annualized growth, while K-12 cross-sell and U.S. pipeline remain strong. Churn and costs are trending down.
Fiscal Year 2025
-
The meeting highlighted strong ARR and margin growth, strategic focus on platform unification, AI integration, and global expansion. Six resolutions were presented and voted on, with no questions raised by shareholders. Key risks discussed included AI's impact on education and mental health.
-
Strong ARR and revenue growth, high gross and service margins, and disciplined cost control drive robust EBITDA and free cash flow outlook. U.S. and U.K. K-12 segments show significant penetration and upside, with new products and AI integration fueling future growth.
-
Achieved record ARR and revenue growth, with strong performance in the U.S. and consumer segments, gross margins over 90%, and robust operating leverage. Guidance calls for continued double-digit growth, higher EBITDA margins, and free cash flow positivity, with no capital raise planned.
-
ARR grew over 25% year-on-year to $137 million, with strong K-12 and consumer segment performance. U.S. and ANZ regions led growth, while U.K. is set for recovery. Cash flow and profitability are improving, with EBITDA margins guided at 10-15% for FY 2025.
-
Recurring revenue grew 26% year-over-year to AUD 132 million, with gross margin rising to 75% and underlying EBITDA turning positive. Cost control and efficiency gains drove profitability, and the outlook remains strong with continued margin expansion and robust sales pipeline.
-
Recorded a strong quarter with ARR up 26% to AUD 132 million, driven by robust U.S. growth and new AI products. Operating cash flow was positive, and cost discipline remains a focus, with EBITDA margin guidance at 10%-15%. Pipeline and innovation position the business for continued outperformance.
-
ARR surpassed AUD 120 million with over 15% year-on-year growth, and free cash flow reached AUD 8.5 million. US and UK markets drive expansion, while cost discipline and product innovation support strong EBITDA margin guidance.
Fiscal Year 2024
-
The meeting highlighted strong financial growth, with recurring revenues, high margins, and positive cash flow. Strategic plans include brand unification, global expansion, and innovation in AI and mental health. All resolutions were presented for shareholder voting, with results to be published on the ASX.